The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders.
 
Douglas Buckner Johnson
Consulting or Advisory Role - Boston Scientific
 
Nikhil I. Khushalani
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech; Provectus
Speakers' Bureau - Prometheus
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Merck (Inst); Pfizer (Inst); Threshold Pharmaceuticals (Inst)
 
Igor Puzanov
No Relationships to Disclose
 
Tejaswi Mudigonda
No Relationships to Disclose
 
Howard Kaufman
Consulting or Advisory Role - Alkermes; Amgen; Merck; Merck Serono; Prometheus
Research Funding - Bristol-Myers Squibb/Medarex
 
Jeffrey Alan Sosman
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline
 
Janice M. Mehnert
Consulting or Advisory Role - Amgen/Dompé (Inst)
Research Funding - Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); polynoma (Inst); Sanofi (Inst)
Other Relationship - Amgen
 
Joseph Clark
Honoraria - Argos Therapeutics; Bristol-Myers Squibb; Novartis; Pfizer; Prometheus
Consulting or Advisory Role - Argos Therapeutics; Novartis; Prometheus
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Pfizer; Prometheus
Research Funding - Bristol-Myers Squibb; Prometheus